Reference : In vivo binding of [F-18]altanserin to rat brain 5HT(2) receptors: A film and electro...
Scientific journals : Article
Human health sciences : Laboratory medicine & medical technology
http://hdl.handle.net/2268/144404
In vivo binding of [F-18]altanserin to rat brain 5HT(2) receptors: A film and electronic autoradiographic study
English
Biver, Françoise [> > > >]
Lotstra, Françoise [> > > >]
Monclus, M. [> > > >]
Dethy, S. [> > > >]
Damhaut, P. [> > > >]
Wikler, D. [> > > >]
Luxen, André mailto [Université de Liège - ULiège > Département de chimie (sciences) > Chimie organique de synthèse - Centre de recherches du cyclotron >]
Goldman, Serge [> > > >]
1997
Nuclear Medicine and Biology
Elsevier Science Inc
24
4
357-360
Yes (verified by ORBi)
International
0969-8051
New York
NY
[en] [18F]Altanserin ; 5HT2 Receptors ; Rat ; Brain ; Autoradiography ; PET
[en] To further validate its use in positron emission tomography (PET), we studied the binding of [18F]altanserin, a specific 5HT2 radioligand, in the rat brain using in vivo autoradiography. Distribution of [18F]altanserin binding was comparable to the in vitro mapping of 5HT2 receptors reported in the literature. Selective displacers were used to test the reversibility and the selectivity of this radioligand. Specific binding of [18F]altanserin in the rat frontal cortex was quantified by direct counting with an electronic imaging system and by quantification on digitalized autoradiograms. Close results of about 30 pmol/g were obtained with both methods. Our data confirmed that [18F]altanserin is a valid tracer for 5HT2 receptors binding studies.
http://hdl.handle.net/2268/144404
10.1016/S0969-8051(97)00054-1
http://www.elsevier.com/wps/find/journaldescription.cws_home/525482/description#description

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Biver_F_1997_Nucl med and biol_24_4_357.pdfNo commentaryAuthor postprint391.22 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.